Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
HALO
HALO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
HALO News
Halozyme Acquires Three Biotech Startups for $1.3 Billion
14h ago
Yahoo Finance
Tech Stocks Struggle While Consumer Staples Shine
Feb 04 2026
Yahoo Finance
Halozyme Raises 2026 Revenue Guidance and Acquires Surf Bio
Jan 28 2026
stocktwits
Halozyme Raises 2026 Financial Guidance Amid Strong Growth
Jan 28 2026
Benzinga
Halozyme Raises Financial Outlook and Acquires Surf Bio for Up to $400M
Jan 28 2026
seekingalpha
Halozyme Raises 2026 Financial Guidance and Acquires Surf Bio
Jan 28 2026
PRnewswire
Halozyme Updates Preliminary 2025 Financial Estimates and Raises 2026 Guidance
Jan 28 2026
Newsfilter
Halozyme and Catalyst Report Double-Digit Revenue Growth, Strong Outlook
Jan 24 2026
NASDAQ.COM
Biotech Recovery: Halozyme and Catalyst Stocks Surge Amid Strong Growth
Jan 24 2026
Fool
Halozyme Therapeutics (HALO) Partners with Takeda, Price Target Raised to $90
Jan 23 2026
Yahoo Finance
Halozyme Therapeutics to Host Investor Call on January 28 for 2025 Revenue Results
Jan 20 2026
PRnewswire
Halozyme Therapeutics (HALO) Market Trends and Investment Opportunities Explored
Jan 20 2026
Fool
Halozyme Therapeutics (HALO) Excluded from Top 10 Stock Picks by Analysts
Jan 20 2026
NASDAQ.COM
Halozyme Enters Exclusive Collaboration with Takeda for ENHANZE® Technology
Jan 08 2026
PRnewswire
Halozyme Enters Exclusive Collaboration with Takeda for ENHANZE® Technology
Jan 08 2026
Newsfilter
Halozyme and Takeda Sign Exclusive Collaboration for ENTYVIO Development
Jan 08 2026
Yahoo Finance
Show More News
